Hims & Hers Health Inc (NYSE:HIMS) shares traded -5.39% lower at $30.87 on Wall Street last session.
HIMS stock price is now 29.53% away from the 50-day moving average and 65.63% away from the 200-day moving average. The market capitalization of the company currently stands at $6.74B.
On August 22, 2024, Needham recently initiated its ‘Buy’ rating on the stock quoting a target price of $24, while ‘Imperial Capital’ rates the stock as ‘In-line’
In other news, Melissa Baird, Officer bought 85,561 shares of the company’s stock on Dec 10 ’24. The stock was bought for $2,641,268 at an average price of $30.87. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 10 ’24, Officer Chi Michael bought 7,259 shares of the business’s stock. A total of $234,103 was incurred on buying the stock at an average price of $32.25. A total of 18.85% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $8.09 and a high of $35.02. As of last week, the company has a debt-to-equity ratio of 0.03, a current ratio of 2.14, and a quick ratio of 1.82. The fifty day moving average price for HIMS is $23.5826 and a two-hundred day moving average price translates $18.53515 for the stock.
The latest earnings results from Hims & Hers Health Inc (NYSE: HIMS) was released for 2024-09-30. The net profit margin was 8.15% and return on equity was 26.35% for HIMS. The company reported revenue of $401.56 million for the quarter, compared to $226.7 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 77.13 percent. For the current quarter, analysts expect HIMS to generate $469.67M in revenue.
